The Lancet Rheumatology, 4(5), e338-e350. Elsevier The Lancet. Rheumatology, 4(5), e338-e350. Elsevier Ltd The Lancet Rheumatology, 4(5), E338-E350. ELSEVIER T2B! immunity against SARS-CoV-2 study group 2022, ' Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants : a cohort study ', The Lancet Rheumatology, vol. 4, no. 5, pp. e338-e350 . https://doi.org/10.1016/S2665-9913(22)00034-0 The Lancet Rheumatology, 4(5), e338-e350. Lancet Publishing Group The Lancet Rheumatology, 4(5), E338-E350. Lancet Publishing Group